Zobrazeno 1 - 10
of 459
pro vyhledávání: '"Rossella Elisei"'
Autor:
Antonio Matrone, Alessio Faranda, Liborio Torregrossa, Carla Gambale, Elisa Minaldi, Alessandro Prete, Luigi De Napoli, Leonardo Rossi, Laura Agate, Virginia Cappagli, Luciana Puleo, Eleonora Molinaro, Gabriele Materazzi, Rossella Elisei
Publikováno v:
Current Oncology, Vol 31, Iss 9, Pp 5528-5536 (2024)
Background: Differentiated thyroid carcinoma (DTC), mainly papillary (PTC), at low risk of recurrence is currently managed with active surveillance strategies or less aggressive surgeries. However, total thyroidectomy with 131I treatment is still per
Externí odkaz:
https://doaj.org/article/1f484435cc76414f89e01429b9d873ae
Autor:
Elisa Minaldi, Virginia Cappagli, Loredana Lorusso, Laura Valerio, Carlotta Giani, Matilde Viglione, Laura Agate, Eleonora Molinaro, Antonio Matrone, Rossella Elisei
Publikováno v:
European Thyroid Journal, Vol 13, Iss 4, Pp 1-10 (2024)
Objective: The aim of this study was to assess the clinical impact of hand–foot syndrome (HFS) during treatment with two multikinase inhibitors, sorafenib and lenvatinib, in a large group of patients with advanced thyroid cancer. Moreover, we looke
Externí odkaz:
https://doaj.org/article/eefb76aa04244b838c70b9c05da9c6ad
Autor:
Carla Gambale, Alessandro Prete, Chiara Romei, Alessandro Celi, Rossella Elisei, Antonio Matrone
Publikováno v:
European Thyroid Journal, Vol 13, Iss 5, Pp 1-7 (2024)
Highly selective RET inhibitor selpercatinib has demonstrated notable efficacy in advanced/progressive RET-mutant medullary thyroid cancer (MTC) patients. However, despite a more tolerable toxicity profile than multikinase inhibitors, peculiar advers
Externí odkaz:
https://doaj.org/article/9480507b61a340388a13e61b404ed49b
Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients
Autor:
Carla Gambale, Alessandro Prete, Lea Contartese, Liborio Torregrossa, Francesca Bianchi, Eleonora Molinaro, Gabriele Materazzi, Rossella Elisei, Antonio Matrone
Publikováno v:
European Thyroid Journal, Vol 12, Iss 6, Pp 1-12 (2023)
Background: Second 131I treatment is commonly performed in clinical practice in patients with differentiated thyroid cancer and biochemical incomplete or indeterminate response (BiR/InR) after initial treatment. Objective: The objective of the is stu
Externí odkaz:
https://doaj.org/article/16dc935259754009ba1e17efc0aa37e8
Autor:
Carla Gambale, José Vicente Rocha, Alessandro Prete, Elisa Minaldi, Rossella Elisei, Antonio Matrone
Publikováno v:
Journal of Imaging, Vol 10, Iss 8, p 189 (2024)
Thyroid nodules in pediatric patients are less common than in adults but show a higher malignancy rate. Accordingly, the management of thyroid nodules in pediatric patients is more complex the younger the patient is, needing careful evaluation by phy
Externí odkaz:
https://doaj.org/article/a07987a595bf4ce7b1fa1757a7a0662e
Autor:
Luigino Dal Maso, Daniela Pierannunzio, Silvia Francisci, Angela De Paoli, Federica Toffolutti, Salvatore Vaccarella, Silvia Franceschi, Rossella Elisei, Ugo Fedeli
Publikováno v:
European Thyroid Journal, Vol 12, Iss 4, Pp 1-6 (2023)
Objective: A decrease in the use of radioactive iodine (RAI) treatment for thyroid cancer has been described in the last decade in the US following subsequent updates of the American Thyroid Association guidelines. By contrast, population-based data
Externí odkaz:
https://doaj.org/article/471f0bbb96d940268d71c133eb8277e2
Publikováno v:
Thyroid Research, Vol 16, Iss 1, Pp 1-5 (2023)
Abstract Background Currently, surgery alone is the gold standard treatment for minimally invasive follicular thyroid cancer (mi-FTC). Case presentation A case of a mi-FTC diagnosed in 1994 was treated with total thyroidectomy and radioiodine (RAI) a
Externí odkaz:
https://doaj.org/article/ae3fd3f7aa1c46d19a4035a3dc908d52
Autor:
Giulia Brigante, Clara Lazzaretti, Elia Paradiso, Federico Nuzzo, Martina Sitti, Frank Tüttelmann, Gabriele Moretti, Roberto Silvestri, Federica Gemignani, Asta Försti, Kari Hemminki, Rossella Elisei, Cristina Romei, Eric Adriano Zizzi, Marco Agostino Deriu, Manuela Simoni, Stefano Landi, Livio Casarini
Publikováno v:
European Thyroid Journal, Vol 11, Iss 5, Pp 1-12 (2023)
To identify a peculiar genetic combination predisposing to diffe rentiated thyroid carcinoma (DTC), we selected a set of single nucleotide polymorphisms (SNPs) associated with DTC risk, considering polygenic risk score (PRS), Bayesian statistics and
Externí odkaz:
https://doaj.org/article/bf321b80eff34b5f987cfbb39ce382d4
Autor:
Luciana Puleo, Laura Agate, Irene Bargellini, Giuseppe Boni, Paolo Piaggi, Claudio Traino, Tommaso Depalo, Giulia Lorenzoni, Francesca Bianchi, Duccio Volterrani, Sandra Brogioni, Valeria Bottici, Maurizia Rossana Brunetto, Barbara Coco, Eleonora Molinaro, Rossella Elisei
Publikováno v:
European Thyroid Journal, Vol 11, Iss 6, Pp 1-10 (2023)
Objectives: Liver metastases occur in 45% of patients with advanced metastatic medullary thyroid cancer (MTC). Transarterial radioembolization (TARE) has been proposed to treat liver metastases (LM), especially in neuroendocrine tumors. The aim of th
Externí odkaz:
https://doaj.org/article/c106a1d41ccb429db0ab11fe8ae0b3f2
Autor:
Chantal A Lebbink, Agnieszka Czarniecka, Renuka P Dias, Rossella Elisei, Louise Izatt, Heiko Krude, Kerstin Lorenz, Markus Luster, Kate Newbold, Arnoldo Piccardo, Manuel Sobrinho-Simões, Toru Takano, A S Paul van Trotsenburg, Frederik A Verburg, Hanneke M van Santen, Thera P Links
Publikováno v:
European Thyroid Journal, Vol 11, Iss 6, Pp 1-40 (2023)
At present, no European recommendations for the management of pediatric thyroid nodules and differentiated thyroid carcinoma (DTC) exist. Differe nces in clinical, molecular, and pathological characteristics between pediatric and adult DTC emphasize
Externí odkaz:
https://doaj.org/article/54df81e109af46dc835dc5782cc169e1